These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23256724)

  • 1. Clonazepam for the treatment of panic disorder.
    Nardi AE; Machado S; Almada LF; Paes F; Silva AC; Marques RJ; Amrein R; Freire RC; Martin-Santos R; Cosci F; Hallak JE; Crippa JA; Arias-Carrión O
    Curr Drug Targets; 2013 Mar; 14(3):353-64. PubMed ID: 23256724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in anxiety sensitivity with pharmacotherapy for panic disorder.
    Simon NM; Otto MW; Smits JA; Nicolaou DC; Reese HE; Pollack MH
    J Psychiatr Res; 2004; 38(5):491-5. PubMed ID: 15380399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine.
    Freire RC; Amrein R; Mochcovitch MD; Dias GP; Machado S; Versiani M; Arias-Carrión O; Carta MG; Nardi AE
    J Clin Psychopharmacol; 2017 Aug; 37(4):429-434. PubMed ID: 28609307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
    Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
    Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
    Worthington JJ; Pollack MH; Otto MW; McLean RY; Moroz G; Rosenbaum JF
    Psychopharmacol Bull; 1998; 34(2):199-205. PubMed ID: 9641001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder.
    Pollack MH; Simon NM; Worthington JJ; Doyle AL; Peters P; Toshkov F; Otto MW
    J Psychopharmacol; 2003 Sep; 17(3):276-82. PubMed ID: 14513919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early coadministration of clonazepam with sertraline for panic disorder.
    Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
    Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind clonazepam vs placebo in panic disorder treatment.
    Valença AM; Nardi AE; Nascimento I; Mezzasalma MA; Lopes FL; Zin W
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1025-9. PubMed ID: 11105068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panic disorder in hospitalized cancer patients.
    Slaughter JR; Jain A; Holmes S; Reid JC; Bobo W; Sherrod NB
    Psychooncology; 2000; 9(3):253-8. PubMed ID: 10871721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal studies of clonazepam in panic disorder.
    Davidson JR; Moroz G
    Psychopharmacol Bull; 1998; 34(2):169-74. PubMed ID: 9640996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic response to benzodiazepine in panic disorder subtypes.
    Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Zin WA; Lopes FL; Versiani M
    Sao Paulo Med J; 2003 Mar; 121(2):77-80. PubMed ID: 12870055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The side effect burden associated with drug treatment of panic disorder.
    Baldwin DS; Birtwistle J
    J Clin Psychiatry; 1998; 59 Suppl 8():39-44; discussion 45-6. PubMed ID: 9707161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical differences between the generic and nongeneric forms of clonazepam.
    Rapaport MH
    J Clin Psychopharmacol; 1997 Oct; 17(5):424. PubMed ID: 9315995
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries.
    Wulsin LR; Maddock R; Beitman B; Dawaher R; Wells VE
    Int J Psychiatry Med; 1999; 29(1):97-105. PubMed ID: 10376236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agitated depression, panic anxiety, and clonazepam.
    Kahn JP
    J Clin Psychiatry; 2006 Dec; 67(12):2034. PubMed ID: 17194291
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonazepam in the treatment of psychiatric disorders: an update.
    Nardi AE; Perna G
    Int Clin Psychopharmacol; 2006 May; 21(3):131-42. PubMed ID: 16528135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram-Clonazepam combination for primary depersonalization disorder: a case report.
    Sachdev P
    Aust N Z J Psychiatry; 2002 Jun; 36(3):424-5. PubMed ID: 12060195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.